Lockheed Martin Corp <LMT.N>: TD Cowen Raises Target Price to $600 From $560
LMT•Related News
Zenas Biopharma posts corporate presentation on autoimmune disease pipeline, led by obexelimab program
ZBIO•
Journey Medical climbs after quarterly revenue beat
DERM•
Sagimet Biosciences Phase 3 Clinical Trial Is On Track To Initiate In Second Half Of 2026
SGMT•
Axos Financial, Inc. <AX.N>: Benchmark raises target price to $120 from $115
AX•
Yunji to report first-half 2026 results, host earnings call
YJ•